The 23 references in paper А. Kadushkin G., А. Taganovich D., L. Kartun V., Е. Hodosovskaya V., V. Chupik N., А. Кадушкин Г., А. Таганович Д., Л. Картун В., Е. Ходосовская В., В. Чупик Н. (2014) “Уровень цитокинов в плазме крови некурящих и курящих пациентов с хронической обструктивной болезнью легких // Plasma cytokine levels in non-smoking and smoking patients with chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2013:i:6:p:27-32

1
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. global initiative for chronic obstructive lung disease (GOLD). 2011.
(check this in PDF content)
2
Salvi S.S., Barnes P.J.Chronic obstructive pulmonary disease in non-smokers. Lancet 2009; 374: 733–743.
(check this in PDF content)
3
Bai P., Sun Y., Jin J. et al. Disturbance of the OPG / RANK / RANKL pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir. Res. 2011; 12: 157.
(check this in PDF content)
4
Tanni S.E., Pelegrino N.R., Angeleli A.Y. et al. Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients. J. Inflamm. 2010; 7: 29.
(check this in PDF content)
5
Lim S.C., Ju J.Y., Chi S.Y. et al. Apoptosis of T lymphocytes isolated from peripheral blood of patients with acute exacerbation of chronic obstructive pulmonary disease. Yonsei Med. J. 2011; 52 (4): 581–587.
(check this in PDF content)
6
Dickens J.A., Miller B.E., Edwards L.D. et al. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respir. Res. 2011; 12: 146.
(check this in PDF content)
7
Schols A.M., Buurman W.A., Staal van den Brekel A.J. et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51 (8): 819–824.
(check this in PDF content)
8
Aaron S.D., Vandemheen K.L., Ramsay T. et al. Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD. Respir. Res. 2010; 11: 41.
(check this in PDF content)
9
Garcia7Rio F., Miravitlles M., Soriano J.B. et al. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir. Res. 2010; 11: 63.
(check this in PDF content)
10
Serapinas D., Narbekovas A., Juskevicius J. et al. Systemic inflammation in COPD in relation to smoking status. Multidiscip. Respir. Med. 2011; 6 (4): 214–219.
(check this in PDF content)
11
Jong J.W., van der Belt7Gritter B., Koeter G.H. et al. Peripheral blood lymphocyte cell subsets in subjects with chronic obstructive pulmonary disease: association with smoking, IgE and lung function. Respir. Med. 1997; 91 (2): 67–76.
(check this in PDF content)
12
World Health Organization. Guidelines for controlling and monitoring the tobacco epidemic. Genewa: WHO; 2008.
(check this in PDF content)
13
Jones P.W., Harding G., Berry P. et al.Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34 (3): 648–654.
(check this in PDF content)
14
Anthonisen N.R., Manfreda J., Warren C.P. et al.Antibiotic therapy in exacerbations of chronic obsructive pulmonary disease. Ann. Intern. Med. 1987; 106 (2): 196–204.
(check this in PDF content)
15
Wanger J., Clausen J.L., Coates A. et al. Standartisation of the measurement of lung volumes. Eur. Respir. J. 2005; 26 (3): 511–522.
(check this in PDF content)
16
Murphy P.M. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin. Hematol. 1997; 34 (4): 311–318.
(check this in PDF content)
17
Rossi G.A. COPD patients or "healthy smokers": is IL\u000f8 syn\u000f thesis and release the borderline? Respiration 2003; 70 (5): 457–459.
(check this in PDF content)
18
Barnes P.J. Mediators of chronic obstructive pulmonary disease. Pharmacol. Rev. 2004; 56 (4): 515–548.
(check this in PDF content)
19
Жестков А.В., Косарев В.В., Бабанов С.А. и др.Клинико-иммунологические особенности профессионального бронхита. Пульмонология 2008; 4: 31–35.
(check this in PDF content)
20
Petrescu F., Voican S.C., Silosi I.Tumor necrosis factor-α serum levels in healthy smokers and nonsmokers. Int. J. Chron. Obsruct. Pulm. Dis. 2010; 5: 217–222.
(check this in PDF content)
21
Shirai T., Suda T., Inui N. et al. Correlation between peripheral blood T-cell profiles and clinical and inflammatory parameters in stable COPD. Allergol. Int. 2010; 59 (1): 75–82.
(check this in PDF content)
22
Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur. Respir. J. 2001; 18 (34): 50s–59s.
(check this in PDF content)
23
Torvinen M., Campwala H., Kilty I. The role of IFN-γin regulation of IFN-γ-inducible protein 10 (IP-10) expression in lung epithelial cell and peripheral blood mononuclear cell co-cultures. Respir. Res. 2007; 8: 80. Информация об авторах
(check this in PDF content)